Finance entity
Of the tracked stories, 2 of 3 also mention Wall Street Zen, the most common co-covered peer. markets accounts for 2 of the 3 tracked stories, while 1 other category carries the remainder. At 5, the average consequence score sits below the same-window beat average of 5.5.
Last mentioned: 56m ago
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Of the tracked stories, 2 of 3 also mention Wall Street Zen, the most common co-covered peer. markets accounts for 2 of the 3 tracked stories, while 1 other category carries the remainder. At 5, the average consequence score sits below the same-window beat average of 5.5. They are less corroborated than the beat average, carrying 2 original sources each against 2.3 for the same window. We currently track 3 Finance stories that mention MarketBeat.com, published between August 13, 2026 and August 16, 2026.
Computed from the 3 stories linked to this entity, with beat comparisons drawn from all 95 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering MarketBeat.com. Shared-story counts are live from our verified record — not editorial picks.
Wall Street Zen downgrades to Hold
Wall Street Zen cut both Klaviyo and Oceaneering International from Buy to Hold in Saturday research notes.
Citigroup lifts KVYO target
Citigroup raised its Klaviyo price target from $34.00 to $36.00 with a Buy rating.
KVYO analyst revisions
Stephens, BTIG, Stifel, and Truist adjusted price targets on Klaviyo following earnings.
Klaviyo Q2 earnings
Klaviyo reported EPS of $0.19, meeting consensus, and revenue of $370.58 million.
OII insider sale
SVP Christopher J. Dyer sold 1,200 OII shares at an average price of $47.65 for $57,180.
Weiss upgrades OII
Weiss Ratings raised OII from Buy (B-) to Buy (B).
Barclays lifts OII target
Barclays increased its OII price objective from $39.00 to $47.00 with an Equal Weight rating.
Citigroup raises OII target
Citigroup raised its Oceaneering target from $35.00 to $40.00 with a Neutral rating.
TD Cowen lifts OII target
TD Cowen raised its Oceaneering International price target from $34.00 to $36.00 with a Hold rating.
Lantern Pharma missed quarterly EPS estimates by $0.19, but shares rose 0.76% to $2.65 on double average volume. The micro-cap trades below both moving averages with a beta of 2.34 and a Sell consensus. Institutional accumulation is scattered and small.
Morgan Stanley trimmed its American Homes 4 Rent target to $38 from $38.50 while keeping an Overweight rating, against a $36.78 consensus and Moderate Buy average. Equity research actions from Jefferies, UBS, RBC, Mizuho, and Compass Point reveal a broadly constructive but price-sensitive stance on the REIT.
Source: themarketsdaily.com · tickerreport.com
Wall Street Zen downgraded both Oceaneering International and Klaviyo from Buy to Hold, spotlighting two $5 billion market-cap companies with vastly different P/E ratios—14.59 for OII and 895.95 for KVYO. The ratings actions come as consensus targets diverge from current prices.
Source: dailypolitical.com · themarketsdaily.com
MarketBeat.com is linked from 3 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
